Isoniazid + Rifampicin

Welcome to Dwaey, specifically on Isoniazid + Rifampicin page.
This medicine contains important and useful components, as it consists of
Isoniazid + Rifampicin is available in the market in concentration.

Generic Name of Isoniazid + Rifampicin - Learn More

Isoniazid + Rifampicin

Isoniazid + Rifampicin Precaution - What You Need to Know

Before starting the combination of isoniazid and rifampicin, it is important for patients to consult their healthcare provider to ensure the safe and appropriate use of these medications. Key precautions include:

- Liver Disease: Both isoniazid and rifampicin can cause liver toxicity, so regular liver function monitoring is crucial, especially in patients with pre-existing liver disease or a history of liver problems. Hepatotoxicity is a serious concern, and treatment should be discontinued if liver damage occurs.
- Alcohol Consumption: Alcohol can exacerbate liver toxicity when used with isoniazid and rifampicin. Patients should avoid alcohol during the course of treatment.
- Peripheral Neuropathy: Isoniazid can cause peripheral neuropathy, leading to symptoms such as numbness, tingling, or pain in the extremities. Vitamin B6 (pyridoxine) supplementation is often recommended to reduce the risk of neuropathy.
- Hematological Monitoring: Rifampicin can cause blood disorders, such as thrombocytopenia (low platelet count) and leukopenia (low white blood cell count). Regular blood tests are recommended to monitor for these effects.
- Pregnancy and Breastfeeding: While this combination can be used in pregnant women when necessary, it is generally avoided in the first trimester unless absolutely required. Both drugs are excreted in breast milk, so breastfeeding mothers should consult a healthcare provider before starting treatment.
- Drug Interactions: This combination regimen can interact with several medications, including anticoagulants (e.g., warfarin), antiepileptics (e.g., phenytoin), and oral contraceptives, necessitating regular monitoring and possible dose adjustments.

Isoniazid + Rifampicin Indication - Uses and Benefits

Isoniazid and rifampicin are primarily used in the treatment of active tuberculosis (TB). Their therapeutic indications include:

- Active Tuberculosis: The combination of isoniazid and rifampicin is one of the core regimens for treating active tuberculosis, particularly for drug-sensitive *Mycobacterium tuberculosis* infections. It is most commonly used in the initial intensive phase of TB therapy (usually for the first two months).
- Latent Tuberculosis: Isoniazid, in combination with rifampicin or alone, may be used in certain cases of latent TB to prevent the progression to active disease.

This regimen is essential for the management of TB and plays a vital role in reducing transmission and preventing resistance development.

Isoniazid + Rifampicin Contraindications - Important Warnings

The combination of isoniazid and rifampicin is contraindicated in several conditions to ensure patient safety:

- Active Liver Disease: Both drugs are known to cause liver toxicity. They should not be used in patients with active liver disease or those with significant liver dysfunction, such as hepatitis or cirrhosis.
- Severe Renal Impairment: In patients with severe renal impairment, particularly those with end-stage renal disease, this combination should be used cautiously and may require dose adjustments.
- Hypersensitivity: Patients with a known allergy or hypersensitivity to isoniazid, rifampicin, or other related compounds should avoid this therapy.
- Pregnancy (First Trimester): The combination may be contraindicated in the first trimester of pregnancy unless the benefits outweigh the risks. Rifampicin has been associated with fetal harm in animal studies, but it may be used during pregnancy if necessary, particularly in cases of active TB.

Isoniazid + Rifampicin Side Effects - What to Expect

The combination of isoniazid and rifampicin can cause various side effects, ranging from mild to severe. Monitoring for these effects is important:

- Common Side Effects:
- Gastrointestinal Issues: Nausea, vomiting, abdominal pain, and loss of appetite are common during treatment.
- Fatigue and Weakness: Patients often experience general fatigue and weakness.
- Skin Rash: A rash may develop, particularly with rifampicin, and can sometimes be a sign of a more serious allergic reaction.

- Serious Side Effects:
- Liver Toxicity (Hepatotoxicity): Both drugs can cause significant liver damage, with symptoms like jaundice, dark urine, and fatigue. Liver function tests should be monitored regularly, and the drugs should be discontinued if liver damage occurs.
- Peripheral Neuropathy: Isoniazid can cause nerve damage, leading to tingling, numbness, or pain in the hands and feet. Vitamin B6 supplementation may help prevent this side effect.
- Hematological Reactions: Rifampicin can cause low platelet counts (thrombocytopenia) and low white blood cell counts (leukopenia), leading to increased risk of infections and bleeding.
- Anaphylactic Reactions: Rarely, an allergic reaction can occur, leading to difficulty breathing, swelling of the face and throat, and a rash. This requires immediate medical attention.
- Orange Discoloration of Bodily Fluids: Rifampicin causes urine, sweat, and tears to become orange-red in color. Although this is harmless, it can be alarming to patients.

Isoniazid + Rifampicin Pregnancy Category ID - Safety Information

3

Isoniazid + Rifampicin Mode of Action - How It Works

The combination of isoniazid and rifampicin works through complementary mechanisms to effectively treat *Mycobacterium tuberculosis*:

- Isoniazid: Isoniazid inhibits the synthesis of mycolic acids, which are vital components of the bacterial cell wall in *Mycobacterium tuberculosis*. This leads to the destruction of the bacterial cell wall and bactericidal action, particularly against actively dividing bacteria.
- Rifampicin: Rifampicin works by binding to the bacterial RNA polymerase enzyme, inhibiting bacterial RNA synthesis. This prevents the bacteria from producing the proteins necessary for survival and reproduction, leading to bactericidal effects.

Together, isoniazid and rifampicin effectively eliminate the bacteria through different mechanisms, reducing the chances of bacterial resistance.

Isoniazid + Rifampicin Drug Interactions - What to Avoid

Isoniazid and rifampicin can interact with a wide variety of drugs, which may either reduce the efficacy of these antibiotics or increase the risk of side effects. Some important interactions include:

- Warfarin (Anticoagulants): Rifampicin accelerates the metabolism of warfarin, reducing its anticoagulant effect and increasing the risk of clotting. INR (international normalized ratio) should be monitored, and warfarin doses may need adjustment.
- Phenytoin (Antiepileptics): Rifampicin can decrease the effectiveness of phenytoin by increasing its metabolism. This may lead to subtherapeutic levels of phenytoin, requiring careful monitoring and dose adjustment.
- Oral Contraceptives: Rifampicin may reduce the efficacy of oral contraceptives by increasing their metabolism, leading to an increased risk of unintended pregnancy. Alternative or additional contraceptive methods should be used.
- Antidiabetic Medications: Rifampicin and isoniazid can affect blood sugar levels, potentially leading to both hypo- or hyperglycemia. Close monitoring of blood glucose is necessary in diabetic patients.
- Alcohol: Alcohol increases the risk of liver toxicity when combined with either isoniazid or rifampicin. Therefore, alcohol should be avoided during treatment.

Isoniazid + Rifampicin Adult Dose - Recommended Dosage

The typical dose for adults with tuberculosis is:

- Isoniazid: 5 mg/kg body weight daily (up to a maximum of 300 mg/day).
- Rifampicin: 10 mg/kg body weight daily (up to a maximum of 600 mg/day).

This combination is usually taken for the first two months in the intensive phase of tuberculosis treatment, after which the regimen is often reduced to include fewer drugs in the continuation phase.

Isoniazid + Rifampicin Child Dose - Dosage for Children

For pediatric patients, the dosing is based on the child’s weight:

- Isoniazid: 10 mg/kg body weight daily (max 300 mg/day).
- Rifampicin: 15 mg/kg body weight daily (max 600 mg/day).

Pediatric dosing should be done under the guidance of a healthcare provider, and the child should be monitored for side effects.

---
As always, it is essential for patients to consult with their healthcare provider before starting isoniazid and rifampicin therapy to ensure it is the right treatment for their condition and to discuss any potential risks or drug interactions.

Isoniazid + Rifampicin Renal Dose - Dosage for Kidney Conditions

For patients with renal impairment, dosing adjustments may be necessary:

- Mild to Moderate Renal Impairment: No significant dose adjustment is typically required. However, the patient should be monitored regularly for potential side effects.
- Severe Renal Impairment: In severe renal impairment, particularly if the patient is on dialysis, the dosing may need to be adjusted or closely monitored to avoid drug accumulation and toxicity.